View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Dec. 13 (HealthDay News) -- More than two thirds of the venous thromboembolism (VTE) complications in cancer patients occur in those undergoing outpatient cancer treatment, according to a study being presented at the annual meeting of the American Society of Hematology, held from Dec. 10 to 13 in San Diego.
Alok Khorana, M.D., from the University of Rochester Medical Center in New York, and colleagues investigated the incidence of VTE in 17,784 cancer patients undergoing chemotherapy. In this retrospective observational study, inpatient and outpatient data were collected from 2005 to 2009 from health care claims databases.
The investigators found that VTE developed in 5.6 percent of the patients. Of the patients who suffered from VTE, the majority (78.3 percent) were being treated on an outpatient basis, and 21 percent had recently been hospitalized. For patients with VTE, the cost of care was twice as high as for patients without VTE.
"The Surgeon General recently issued a Call to Action to reduce VTE. At this point, public health efforts have focused on inpatient prophylaxis. These new data suggest that to reduce the burden of VTE in cancer patients, prevention efforts will have to shift to the outpatient arena as well," Khorana said in a statement.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top